Texas Original Opens Drive-Thru Medical Cannabis Pickup Location in Waco, Texas
Ryan Allway
June 28th, 2022
News, Top News
AUSTIN, Texas, June 28, 2022–(BUSINESS WIRE)–Texas Original, Texas’ leading medical cannabis provider, announced its newest prescription pickup location has opened in Waco, Texas. The new location is Waco’s first medical cannabis pickup site and the first drive-thru location in the state. The pickup location is open every Friday between 10:30 a.m. and 2 p.m. for patients who qualify under the Compassionate Use Program.
Texas Original operates the most robust medical cannabis distribution network in Texas. In addition to its convenient pickup locations open weekly throughout the state, the company also delivers prescriptions directly to patients’ doorsteps on a daily and weekly basis. The Waco opening marks another important milestone in the company’s pursuit of expanding access to life-changing medical cannabis treatment for every Texan. Waco-area patients like Barry Freeman—who uses medical cannabis to treat symptoms of PTSD—now have a convenient option to pick up their prescriptions locally.
“Medical cannabis has helped me sleep better, live without the burden of chronic pain and eliminate pain pills from my treatment,” Freeman said. “Texas Original’s medicine has changed my life and I’m so grateful to have nearby access to their products through the Waco pickup location.”
Registered physicians can prescribe medical cannabis to treat conditions including epilepsy, cancer, PTSD and hundreds of neurodegenerative disorders. Texas Original’s medicine alleviates common symptoms—including chronic pain, insomnia and anxiety—associated with such conditions for thousands of patients. Qualifying Waco residents can obtain medical cannabis prescriptions through online clinics or Waco-based physicians registered with the Compassionate Use Registry of Texas.
“Getting your medical cannabis prescription filled should be as easy as picking up any other medicine,” said Morris Denton, CEO of Texas Original. “Swiftly receiving care from the comfort of your car is another significant step toward expanding access for our patients. I encourage Waco residents to ask their doctors about the life-changing benefits of medical cannabis and reach out to us to start experiencing relief as soon as possible.”
Waco patients can continue to access their prescriptions through Texas Original’s delivery network. Today’s announcement also follows the opening of Texas Original’s first permanent medical cannabis pickup location in Houston, which serves the greater Houston area five days a week. Operating times for the company’s permanent Houston Heights location and other local pickup sites can be found on the Texas Original website here.
Texas Original’s suite of gummies, tincture and lozenge products are also available for pickup at the company’s dispensary in Austin, Texas. To learn whether you or a loved one qualifies for medical cannabis, visit www.texasoriginal.com/patients.
About Texas Original
Texas Original is the leading licensed medical cannabis producer in Texas, working alongside physicians to provide the highest quality cannabis medicine to patients and families seeking relief across the state. As fellow Texans, we are dedicated to representing the integrity of this great state with our commitment to quality, consistency and purity in every product we produce. We remain committed to advancing safe, legal access to this powerful medicine. Texas Original is headquartered in Austin, with delivery throughout the entire state. For more information, visit www.texasoriginal.com.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
Revive Therapeutics’ cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease.
KetamineOne Capital is focused on consolidating medical clinics and becoming a North American leader in mental health treatments.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
